The Valley Desk

LetterJournal of the European Academy of Dermatology and Venereology : JEADVPublished

Relapse prediction in rituximab-treated pemphigus patients: A prognostic model

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Temple University. Affiliation source

Publication record

Type
Letter
Venue
Journal of the European Academy of Dermatology and Venereology : JEADV
Published
Subject terms
Pemphigus; Relapse; Rituximab; Baseline Characteristics; Relapse‐free Survival; Independent Factors
PubMed ID
42466670
Added to directory
Source checked

Report a correction or request removal